|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|
| Revenue | |||
| Grant | |||
| Product revenue, net | |||
| Total revenue | |||
| Total revenue, net | |||
| Operating expenses: | |||
| Cost of product sold | |||
| Research and development | |||
| Selling, general and administrative | |||
| Total operating expenses | |||
| Loss from operations | |||
| Other income | |||
| Net loss and comprehensive loss | |||
| Net loss per share, basic and diluted | |||
| Weighted average shares used in the calculation of net loss per share, basic and diluted: | |||
| Net loss per share - basic | |||
| Net loss per share - diluted | |||
| Weighted average shares used in the calculation of net loss per share, basic | |||
| Weighted average shares used in the calculation of net loss per share, diluted |
Loading...
